<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01443013</url>
  </required_header>
  <id_info>
    <org_study_id>NI08031</org_study_id>
    <secondary_id>AOM09031</secondary_id>
    <nct_id>NCT01443013</nct_id>
  </id_info>
  <brief_title>Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient</brief_title>
  <acronym>TUFEV</acronym>
  <official_title>Predictive Value Analysis of Messenger Ribonucleic Acid (mRNA) Urinary Expression of Foxp3 and Vimentin on Graft Outcome in Renal Transplant Recipient: National Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational study is designed to analyse the urinary mRNA expression of Foxp3 and
      Vimentin, two genes involved in tolerance and early graft dysfunction in 500 renal transplant
      recipients from 17 renal transplant site in France and to determine the predictive value of
      these gene expression on the one year graft outcome including graft function, one-year graft
      histological analysis and incidence of acute rejection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This observational study is designed to analyse the urinary mRNA expression of Foxp3 and
      Vimentin, two genes involved in tolerance and early graft dysfunction in 500 renal transplant
      recipients from 17 renal transplant site in France and to determine the predictive value of
      these gene expression on the one year graft outcome including graft function,
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Foxp3 and Vimentin mRNA expression</measure>
    <time_frame>at Month 1,3,6 and 12</time_frame>
    <description>evaluation at month 9 suppressed by amendment n°2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Renal biopsy</measure>
    <time_frame>at Month 12</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">266</enrollment>
  <condition>Function of Renal Transplant</condition>
  <arm_group>
    <arm_group_label>Cohort of Renal Transplant recipients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Renal Transplant</intervention_name>
    <description>urinary sample at month 3, 6 and 12</description>
    <arm_group_label>Cohort of Renal Transplant recipients</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine for mRNA extraction and congelation
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All Renal transplant recipients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All renal transplant recipients aged &gt;18 years with informed consent

          -  Kidney transplantation in one of the centers participating in the study all patients
             registered on the waiting list to the Agency of Biomedicine

          -  Supported by a conventional procedure

          -  Informed consent signed.

          -  No pregnancy or lactation in progress.

          -  Serology HIV and (HCV negative suppressed by amendment n°2)

          -  No contraindication for a biopsy at 1 year post transplant

        Exclusion Criteria:

          -  Positive crossmatch, focal segmental glomerulosclerosis (FSGS) as primary nephropathy,
             HIV positive population

          -  Absence of registration on the waiting list for transplantation with the Agency of
             Biomedicine

          -  HIV-positive serology

          -  Chronic renal failure secondary to focal segmental hyalinosis

          -  Cross-match historical or cross match of the day positive T or B awareness

          -  Patient included in a Memorandum of industry (suppressed by amendment n°1)

          -  No affiliation to a social security scheme

          -  Patients with early failure due to immediate complications (4%) will be included but
             will not be considered for analysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Grimbert, MD PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Henri Mondor Hospital</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Aquino-Dias EC, Joelsons G, da Silva DM, Berdichevski RH, Ribeiro AR, Veronese FJ, Gonçalves LF, Manfro RC. Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function. Kidney Int. 2008 Apr;73(7):877-84. doi: 10.1038/sj.ki.5002795. Epub 2008 Jan 23. Erratum in: Kidney Int. 2008 Aug;74(3):393. Veronose, F J V [corrected to Veronese, F J V]; Berdichewski, R H [corrected to Berdichevski, R H].</citation>
    <PMID>18216781</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2011</study_first_submitted>
  <study_first_submitted_qc>September 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2011</study_first_posted>
  <last_update_submitted>October 18, 2015</last_update_submitted>
  <last_update_submitted_qc>October 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tolerance</keyword>
  <keyword>Renal Transplantation</keyword>
  <keyword>Chronic allograft nephropathy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

